VectraCor Announces Compliance With European Medical Device Regulation (MDR)
Totowa, NJ May 5th, 2022 // VectraCor Inc., an international provider of patented cardio-pulmonary devices, is proud to announce that its VectraplexECG System and Universal SmartECG devices are now compliant to the European Union’s (EU) strictest medical device regulation MDR 2017/745. VectraCor’s notified body, BSI, issued the MDR 2017/745 certificate, effective May 4th 2022, declaring that the submitted VectraCor products conform to the outlined regulations and are approved to display the CE mark under this new standard which addresses both devices and software.
Cardiac Electrical Biomarker (CEB®)
Detects ECG changes suggestive of a heart attack.
Email Capability
Allows you to email an ECG report to anyone.
EMR Connectivity
We connect to most major EMR systems.
What we do?
VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack and derive a 15-22 lead ECG utilizing only 5-electrodes. We have a entire suite of products that are durable, mobile, and ready to turn an off-the-shelf tablet or laptop into a medical device. Our products are FDA cleared, CE marked, and VectraCor is ISO-13485 certified.
Cardiac Electrical Biomarker (CEB®)
Detects ECG changes suggestive of a heart attack.
Email Capability
Allows you to email an ECG report to anyone.
EMR Connectivity
We connect to most major EMR systems.
What we do?
VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack and derive a 15-22 lead ECG utilizing only 5-electrodes. We have a entire suite of products that are durable, mobile, and ready to turn an off-the-shelf tablet or laptop into a medical device. Our products are FDA cleared, CE marked, and VectraCor is ISO-13485 certified.
Cardiac Electrical Biomarker (CEB®)
Detects ECG changes suggestive of a heart attack.
Email Capability
Allows you to email an ECG report to anyone.
EMR Connectivity
We connect to most major EMR systems.
Cardiac Electrical Biomarker (CEB®)
Detects ECG changes suggestive of a heart attack.
Email Capability
Allows you to email an ECG report to anyone.
EMR Connectivity
We connect to most major EMR systems.
What we do?
VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack and derive a 15-22 lead ECG utilizing only 5-electrodes. We have a entire suite of products that are durable, mobile, and ready to turn an off-the-shelf tablet or laptop into a medical device. Our products are FDA cleared, CE marked, and VectraCor is ISO-13485 certified.
